Vanderbilt University Medical Center has received a five-year, $4.5 million grant from the National Human Genome Research Institute to assess clinical outcomes and economic value of screening large, diverse health care populations for disease risk using polygenic risk scores.

Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.

A study of more than 70,000 trauma patients found that those who received care from a service with a high proportion of physicians modeling unprofessional behavior were at a 24% increased risk of death or complications.

Vanderbilt's Nicole Ward, PhD, was one of three honorees who were the focus of attention at the National Psoriasis Foundation’s 2022 Commit to Cure Gala: Celebrating Women Who Lead, held recently in Chicago.

Sara Horst, MD, MPH, associate professor of Medicine, and Barron Patterson, MD, associate professor of Pediatrics, have received 2022 Physician Builder Awards.

Vanderbilt University Medical Center is among 11 centers that will pilot a new federally sponsored training program, the Joint Infectious Diseases/Epidemic Intelligence Service (ID/EIS) Fellowship.